Sotabase

Career

· Member Of Technical Staff, xAI2024–
· at University of Illinois, Urbana-Champaign2021–2021
· S21, Y Combinator2021–2021
· Applied Scientist, Amazon Web Services (AWS)2020–2020
· Co-Founder COO CSO, Revery.AI2020–2024
· NLP Researcher, Tencent America2019–2019
· Researcher, University of Illinois at Urbana-Champaign2018–2020
· Reseacher, University of California, Berkeley2017–2018
· Researcher, University of California, Berkeley2016–2018
· Computer Vision Intern, Vercury Inc.2015–2015
· Bachelor's degree, Computer Science, University of California, Berkeley2014–2018
· Computer Software Intern, Vercury Inc.2014–2014
· Doctor of Philosophy - PhD, Computer Vision, University of Illinois at Urbana-Champaign

Publications (42)

Fully Automated Echocardiogram Interpretation in Clinical Practice
Circulation · 2018
740
cited
An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia.
Sleep Medicine · 2006
278
cited
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.
Sleep Medicine · 2006
268
cited
Evaluation of the efficacy and safety of ramelteon in subjects with chronic insomnia.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2007
182
cited
A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia
Current Medical Research and Opinion · 2007
135
cited
Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial
Critical Care · 2020
68
cited
Long‐term edaravone efficacy in amyotrophic lateral sclerosis: Post‐hoc analyses of Study 19 (MCI186‐19)
Muscle and Nerve · 2019
68
cited
The effects of ramelteon on respiration during sleep in subjects with moderate to severe chronic obstructive pulmonary disease
Sleep and Breathing · 2009
64
cited
Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year, open-label study.
Journal of Clinical Psychiatry · 2009
49
cited
ILLIXR: Enabling End-to-End Extended Reality Research
IEEE International Symposium on Workload Characterization · 2021
48
cited
Effect of Ramelteon, a selective MT1/MT2-receptor agonist, on respiration during sleep in mild to moderate COPD
Sleep and Breathing · 2008
41
cited
Intravenous edaravone treatment in ALS and survival: An exploratory, retrospective, administrative claims analysis
EClinicalMedicine · 2022
37
cited
Auxora vs. placebo for the treatment of patients with severe COVID-19 pneumonia: a randomized-controlled clinical trial
Critical Care · 2022
30
cited
A Computer Vision Pipeline for Automated Determination of Cardiac Structure and Function and Detection of Disease by Two-Dimensional Echocardiography
2017
23
cited
Edaravone efficacy in amyotrophic lateral sclerosis with reduced forced vital capacity: Post-hoc analysis of Study 19 (MCI186-19) [clinical trial NCT01492686]
PLoS ONE · 2022
22
cited
Post-hoc analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · 2019
18
cited
Real Robot Challenge: A Robotics Competition in the Cloud
Neural Information Processing Systems · 2021
16
cited
ILLIXR: An Open Testbed to Enable Extended Reality Systems Research
IEEE Micro · 2022
15
cited
Factors Influencing Infusion-Related Reactions Following Dosing of Reference Rituximab and PF-05280586, a Rituximab Biosimilar
BioDrugs · 2021
13
cited
PF-06881893 (Nivestym™), a Filgrastim Biosimilar, Versus US-Licensed Filgrastim Reference Product (US-Neupogen®): Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Safety of Single or Multiple Subcutaneous Doses in Healthy Volunteers
BioDrugs · 2019
13
cited
Sotabase
Jeffrey Zhang | Researcher Profile | Sotabase | Sotabase